English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
InaVac gets emergency approval from BPOM
Nov 14, 2022 11:30 HKT
Novotech, 동서 MRCT 전략 구축 및 자금 조달 방법에 대한 바이오 센추리 정상회담 워크숍 의장
Nov 12, 2022 14:00 HKT
Novotech 主持关于如何建立和资助东西方 MRCT 战略的 BioCentury 峰会研讨会
Nov 12, 2022 08:00 HKT
Novotech 主持關於如何建立和資助東西方 MRCT 戰略的 BioCentury 峰會研討會
Nov 12, 2022 08:00 HKT
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Nov 11, 2022 17:00 HKT
君联资本所投企业巨子生物在港交所成功上市
Nov 09, 2022 08:46 HKT
君聯資本所投企業巨子生物在港交所成功上市
Nov 09, 2022 08:45 HKT
新股上市 心泰医疗(2291.HK)今日于港交所上市 暗盘收涨2.23%
Nov 08, 2022 08:56 HKT
新股上市 心泰醫療(2291.HK)今日於港交所上市 暗盤收漲2.23%
Nov 08, 2022 08:55 HKT
Sirnaomics已完成STP705用于成人腹部减脂医学美容治疗的首例受试者给药
Nov 08, 2022 08:45 HKT
Sirnaomics已完成STP705用於成人腹部減脂醫學美容治療的首例受試者給藥
Nov 08, 2022 08:44 HKT
Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment
Nov 08, 2022 08:43 HKT
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
Nov 07, 2022 15:49 HKT
中国抗体宣布委任王善春先生为中国区总裁
Nov 04, 2022 17:49 HKT
中國抗體宣佈委任王善春先生為中國區總裁
Nov 04, 2022 17:48 HKT
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company
Nov 04, 2022 17:47 HKT
研发实力强劲业绩增长亮眼 百奥赛图捷报频传未来可期
Nov 03, 2022 14:33 HKT
研發實力強勁業績增長亮眼 百奧賽圖捷報頻傳未來可期
Nov 03, 2022 14:32 HKT
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Nov 01, 2022 17:51 HKT
Avance Clinical赞助全球Scrip奖项的中国生物制药奖
Oct 27, 2022 08:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: